ESC Premium Access

Time to event analysis in patients managed on rivaroxaban while taking concurrent interacting medications (CIM)

Congress Presentation

About the speaker

Doctor Jeffrey Michel

Baylor Scott and White Health, Austin (United States of America)
0 follower

5 more presentations in this session

Aspirin resistance in patients with stable coronary heart disease

Speaker: Doctor T. Petroni (Montauban, FR)


CYP2C19-dependent clopidogrel resistance is a possible cause for coronary stent and peripheral bypass occlusion

Speaker: Assistant Professor M. Klinceva (Skopje, MK)


Fourier-spectroscopy capacity in assessment of resistance to acetylsalicylic acid in patients with stable angina pectoris

Speaker: Mrs A. Kosinova (Krasnoyarsk, RU)


Residual risk following myocardial infarction despite intensive medical management

Speaker: Professor R. Rosenson (New York, US)


Role of rivaroxaban in left ventricular thrombi

Speaker: Doctor A. Almaghraby (Ras al Khaimah, AE)


Access the full session

Poster Session 1 - Antiplatelet and anticoagulant drugs

Speakers: Doctor J. Michel, Doctor T. Petroni, Assistant Professor M. Klinceva, Mrs A. Kosinova, Professor R. Rosenson...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb